ARCHIVES

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

In Brief: Rhoads, Schmidt Bow Out – Amos, Krim Possible Replacements; Sibal acting Virology Director

January 27, 1978

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

December 26, 2003

Flow Lab Lands Top Virology Contract – $1.9 Mil.

February 21, 1975

In Brief: Twenty Apply for ICC Director Job, DeVita Says 30 More Centers Needed; PAP Awards To Clark, Fox

March 18, 1983

In This Issue: The controversy Over “Cancer Undefeated”

June 6, 1997